Skip to main content
Erschienen in: Neurological Sciences 5/2021

25.11.2020 | Letter to the Editor

Cranial multineuropathy with hypoglossal nerve involvement in a patient with anti-Ku autoantibodies

verfasst von: Chiara Sist, Mara Turri, Igor Florio, Francesco Teatini

Erschienen in: Neurological Sciences | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Excerpt

Cranial multineuropathy involving facial and trigeminal nerves is a well-described possible manifestation of an autoimmune disease associated with anti-Ku antibodies. We present the case of a patient with anti-Ku antibodies and monolateral hypoglossal palsy. …
Literatur
1.
Zurück zum Zitat Belizna C, Henrion D, Buecher A et al (2010) Anti-Ku antibodies: clinical, genetics and diagnostic insights. Autoimmun Rev 9:691–694CrossRef Belizna C, Henrion D, Buecher A et al (2010) Anti-Ku antibodies: clinical, genetics and diagnostic insights. Autoimmun Rev 9:691–694CrossRef
2.
Zurück zum Zitat Rigolet A, Musset L, Dubourg O et al (2012) Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease. Medicine 91:95–102CrossRef Rigolet A, Musset L, Dubourg O et al (2012) Inflammatory myopathies with anti-Ku antibodies: a prognosis dependent on associated lung disease. Medicine 91:95–102CrossRef
3.
Zurück zum Zitat Postolova A, Chen JK, Chung L (2016) Corticosteroids in myositis and scleroderma. Rheum Dis Clin North Am 42(1):103–118CrossRef Postolova A, Chen JK, Chung L (2016) Corticosteroids in myositis and scleroderma. Rheum Dis Clin North Am 42(1):103–118CrossRef
4.
Zurück zum Zitat Fernández-Codina A, Walker KM, Pope JE (2018) Scleroderma algorithm group. Treatment Algorithms for systemic sclerosis according to experts. Arthritis Rheumatol 70(11):1820–1828CrossRef Fernández-Codina A, Walker KM, Pope JE (2018) Scleroderma algorithm group. Treatment Algorithms for systemic sclerosis according to experts. Arthritis Rheumatol 70(11):1820–1828CrossRef
5.
Zurück zum Zitat Oddis CV, Reed AM, Aggarwal R et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65:314–324CrossRef Oddis CV, Reed AM, Aggarwal R et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65:314–324CrossRef
Metadaten
Titel
Cranial multineuropathy with hypoglossal nerve involvement in a patient with anti-Ku autoantibodies
verfasst von
Chiara Sist
Mara Turri
Igor Florio
Francesco Teatini
Publikationsdatum
25.11.2020
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 5/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04912-6

Weitere Artikel der Ausgabe 5/2021

Neurological Sciences 5/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.